BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 32852523)

  • 1. A third Notch in colorectal cancer progression and metastasis.
    Koch U; Radtke F
    J Exp Med; 2020 Oct; 217(10):. PubMed ID: 32852523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AKT-dependent NOTCH3 activation drives tumor progression in a model of mesenchymal colorectal cancer.
    Varga J; Nicolas A; Petrocelli V; Pesic M; Mahmoud A; Michels BE; Etlioglu E; Yepes D; Häupl B; Ziegler PK; Bankov K; Wild PJ; Wanninger S; Medyouf H; Farin HF; Tejpar S; Oellerich T; Ruland J; Siebel CW; Greten FR
    J Exp Med; 2020 Oct; 217(10):. PubMed ID: 32749453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear Notch3 expression is associated with tumor recurrence in patients with stage II and III colorectal cancer.
    Ozawa T; Kazama S; Akiyoshi T; Murono K; Yoneyama S; Tanaka T; Tanaka J; Kiyomatsu T; Kawai K; Nozawa H; Kanazawa T; Yamaguchi H; Ishihara S; Sunami E; Kitayama J; Morikawa T; Fukayama M; Watanabe T
    Ann Surg Oncol; 2014 Aug; 21(8):2650-8. PubMed ID: 24728738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations of non-pedunculated T1 colorectal adenocarcinoma outcome with consensus molecular subtypes, immunoscore, and microsatellite status: a multicenter case-cohort study.
    Haasnoot KJC; Backes Y; Moons LMG; Kranenburg O; Trinh A; Vermeulen L; Noë M; Tuynman JB; van Lent AUG; van Ginneken R; Seldenrijk CA; Raicu MG; Trumpi K; Ubink I; Milne AN; Boonstra JJ; Groen JN; Schwartz MP; Wolfhagen FHJ; Geesing JMJ; Ter Borg F; Brosens LAA; van Bergeijk J; Spanier BWM; de Vos Tot Nederveen Cappel WH; Kessels K; Seerden TCJ; Vleggaar FP; Offerhaus GJA; Siersema PD; Elias SG; Laclé MM;
    Mod Pathol; 2020 Dec; 33(12):2626-2636. PubMed ID: 32581367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FAM225A facilitates colorectal cancer progression by sponging miR-613 to regulate NOTCH3.
    Zhang X; Shi H; Yao J; Li Y; Gao B; Zhang Y; Wang C; Zhou H; Zhang L
    Cancer Med; 2020 Jun; 9(12):4339-4349. PubMed ID: 32343052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interconnectivity between molecular subtypes and tumor stage in colorectal cancer.
    Coebergh van den Braak RRJ; Ten Hoorn S; Sieuwerts AM; Tuynman JB; Smid M; Wilting SM; Martens JWM; Punt CJA; Foekens JA; Medema JP; IJzermans JNM; Vermeulen L
    BMC Cancer; 2020 Sep; 20(1):850. PubMed ID: 32887573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NOTCH3 signaling regulates MUSASHI-1 expression in metastatic colorectal cancer cells.
    Pastò A; Serafin V; Pilotto G; Lago C; Bellio C; Trusolino L; Bertotti A; Hoey T; Plateroti M; Esposito G; Pinazza M; Agostini M; Nitti D; Amadori A; Indraccolo S
    Cancer Res; 2014 Apr; 74(7):2106-18. PubMed ID: 24525742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NOTCH3 expression is linked to breast cancer seeding and distant metastasis.
    Leontovich AA; Jalalirad M; Salisbury JL; Mills L; Haddox C; Schroeder M; Tuma A; Guicciardi ME; Zammataro L; Gambino MW; Amato A; Di Leonardo A; McCubrey J; Lange CA; Liu M; Haddad T; Goetz M; Boughey J; Sarkaria J; Wang L; Ingle JN; Galanis E; D'Assoro AB
    Breast Cancer Res; 2018 Sep; 20(1):105. PubMed ID: 30180881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LIN28B promotes cell invasion and colorectal cancer metastasis via CLDN1 and NOTCH3.
    Sugiura K; Masuike Y; Suzuki K; Shin AE; Sakai N; Matsubara H; Otsuka M; Sims PA; Lengner CJ; Rustgi AK
    JCI Insight; 2023 Jul; 8(14):. PubMed ID: 37318881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Notch3 signaling promotes colorectal tumor growth by enhancing immunosuppressive cells infiltration in the microenvironment.
    Huang K; Luo W; Fang J; Yu C; Liu G; Yuan X; Liu Y; Wu W
    BMC Cancer; 2023 Jan; 23(1):55. PubMed ID: 36647017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-384 inhibits human colorectal cancer metastasis by targeting KRAS and CDC42.
    Wang YX; Chen YR; Liu SS; Ye YP; Jiao HL; Wang SY; Xiao ZY; Wei WT; Qiu JF; Liang L; Liao WT; Ding YQ
    Oncotarget; 2016 Dec; 7(51):84826-84838. PubMed ID: 27769041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The overexpression of AUF1 in colorectal cancer predicts a poor prognosis and promotes cancer progression by activating ERK and AKT pathways.
    Tian XY; Li J; Liu TH; Li DN; Wang JJ; Zhang H; Deng ZL; Chen FJ; Cai JP
    Cancer Med; 2020 Nov; 9(22):8612-8623. PubMed ID: 33016643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Consensus molecular subtype classification of colorectal adenomas.
    Komor MA; Bosch LJ; Bounova G; Bolijn AS; Delis-van Diemen PM; Rausch C; Hoogstrate Y; Stubbs AP; de Jong M; Jenster G; van Grieken NC; Carvalho B; Wessels LF; Jimenez CR; Fijneman RJ; Meijer GA;
    J Pathol; 2018 Nov; 246(3):266-276. PubMed ID: 29968252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subtype-specific kinase dependency regulates growth and metastasis of poor-prognosis mesenchymal colorectal cancer.
    Buikhuisen JY; Gomez Barila PM; Cameron K; Suijkerbuijk SJE; Lieftink C; di Franco S; Krotenberg Garcia A; Uceda Castro R; Lenos KJ; Nijman LE; Torang A; Longobardi C; de Jong JH; Dekker D; Stassi G; Vermeulen L; Beijersbergen RL; van Rheenen J; Huveneers S; Medema JP
    J Exp Clin Cancer Res; 2023 Mar; 42(1):56. PubMed ID: 36869386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinoic acid-induced 2 (RAI2) is a novel tumor suppressor, and promoter region methylation of RAI2 is a poor prognostic marker in colorectal cancer.
    Yan W; Wu K; Herman JG; Xu X; Yang Y; Dai G; Guo M
    Clin Epigenetics; 2018; 10():69. PubMed ID: 29796120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consensus molecular subtype differences linking colon adenocarcinoma and obesity revealed by a cohort transcriptomic analysis.
    Greene MW; Abraham PT; Kuhlers PC; Lipke EA; Heslin MJ; Wijaya ST; Odeniyi I
    PLoS One; 2022; 17(5):e0268436. PubMed ID: 35560039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disruption of the c-Myc/miR-200b-3p/PRDX2 regulatory loop enhances tumor metastasis and chemotherapeutic resistance in colorectal cancer.
    Lv Z; Wei J; You W; Wang R; Shang J; Xiong Y; Yang H; Yang X; Fu Z
    J Transl Med; 2017 Dec; 15(1):257. PubMed ID: 29258530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-206 attenuates tumor proliferation and migration involving the downregulation of NOTCH3 in colorectal cancer.
    Wang XW; Xi XQ; Wu J; Wan YY; Hui HX; Cao XF
    Oncol Rep; 2015 Mar; 33(3):1402-10. PubMed ID: 25607234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SEMA3F prevents metastasis of colorectal cancer by PI3K-AKT-dependent down-regulation of the ASCL2-CXCR4 axis.
    Zhou ZH; Rao J; Yang J; Wu F; Tan J; Xu SL; Ding Y; Zhan N; Hu XG; Cui YH; Zhang X; Dong W; Liu XD; Bian XW
    J Pathol; 2015 Aug; 236(4):467-78. PubMed ID: 25866254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prognostic six-gene expression risk-score derived from proteomic profiling of the metastatic colorectal cancer secretome.
    Robles J; Pintado-Berninches L; Boukich I; Escudero B; de Los Rios V; Bartolomé RA; Jaén M; Martín-Regalado Á; Fernandez-Aceñero MJ; Imbaud JI; Casal JI
    J Pathol Clin Res; 2022 Nov; 8(6):495-508. PubMed ID: 36134447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.